Etidronate disodium

依替膦酸二钠

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameEtidronate disodium
Drug Alias NameEtidronic acid disodium salt羟乙膦酸钠依膦Acidum etidronicum依替膦酸钠 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone resorption factor inhibitors
TargetsBone resorption factor
Therapy Area/IndicationsOssification, HeterotopicOsteitis DeformansOsteoporosis
Global Approved IndicationsOssification, HeterotopicOsteitis DeformansOsteoporosis
Approved Indications in ChinaOsteoporosis
Original Approved Country/TerritoryUnited States
Original Approved Date1977/09/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDainippon Sumitomo Pharma Co LtdLianyungang Runzhong Pharmaceutical Co LtdJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesAllergan Pharmaceuticals International Ltd
Active IndicationsOssification, HeterotopicOsteitis DeformansOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeM05BA01
Related LinksWikipediaDrugBankKEGG